Adaptive, Microsoft to develop universal TCR-antigen map

Adaptive Biotechnologies Corp. (Seattle, Wash.) and Microsoft Corp.(NASDAQ:MSFT) partnered to develop a universal map of T cell receptors (TCRs) and their

Read the full 217 word article

User Sign In